Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

1.46
-0.0420-2.80%
Post-market: 1.21-0.2479-17.00%19:59 EDT
Volume:1.15M
Turnover:1.74M
Market Cap:2.56M
PE:-0.29
High:1.57
Open:1.50
Low:1.45
Close:1.50
52wk High:10.87
52wk Low:1.45
Shares:1.75M
Float Shares:1.52M
Volume Ratio:17.81
T/O Rate:75.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0667
EPS(LYR):-7.5654
ROE:-91.23%
ROA:-44.25%
PB:0.52
PE(LYR):-0.19

Loading ...

Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Correspondence

Form CORRESP - Correspondence
Aug 21, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 27, 2024

Correspondence

Form CORRESP - Correspondence
Jul 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 27, 2024

Correspondence

Form CORRESP - Correspondence